Evidence map›Paper›PMID 38871840›Full record

ArticleActa neuropathologica2024

Correction to: Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs.

Yingli Zhu, Thibaut Burg, Katrien Neyrinck, Tim Vervliet, Fatemeharefeh Nami, Ellen Vervoort, Karan Ahuja, Maria Livia Sassano, Yoke Chin Chai, Arun Kumar Tharkeshwar and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Yingli ZhuDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000, Leuven, Belgium. zhuyingli1992@163.com.ORCID http://orcid.org/0000-0002-8987-4673
Thibaut BurgDepartment of Neurosciences, Experimental Neurology, KU Leuven, Leuven Brain Institute (LBI), 3000, Leuven, Belgium.
Katrien NeyrinckDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000, Leuven, Belgium.
Tim VervlietLaboratory of Molecular and Cellular Signalling, Department of Cellular and Molecular Medicine, KU Leuven, 3000, Leuven, Belgium.
Fatemeharefeh NamiDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000, Leuven, Belgium.
Ellen VervoortLaboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, KU Leuven, 3000, Leuven, Belgium.
Karan AhujaDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000, Leuven, Belgium.
Maria Livia SassanoLaboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, KU Leuven, 3000, Leuven, Belgium.
Yoke Chin ChaiDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000, Leuven, Belgium.
Arun Kumar TharkeshwarDepartment of Neurosciences, Experimental Neurology, KU Leuven, Leuven Brain Institute (LBI), 3000, Leuven, Belgium.
Jonathan De SmedtDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000, Leuven, Belgium.
Haibo HuNational Engineering Research Center for Modernization of Traditional Chinese Medicine-Hakka Medical Resources Branch, School of Pharmacy, Gannan Medical University, Ganzhou, China.
Geert BultynckLaboratory of Molecular and Cellular Signalling, Department of Cellular and Molecular Medicine, KU Leuven, 3000, Leuven, Belgium.
Patrizia AgostinisLaboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, KU Leuven, 3000, Leuven, Belgium.
Johannes V SwinnenLaboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, 3000, Leuven, Belgium.
Ludo Van Den BoschDepartment of Neurosciences, Experimental Neurology, KU Leuven, Leuven Brain Institute (LBI), 3000, Leuven, Belgium.
Rodrigo Furtado Madeiro da CostaDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000, Leuven, Belgium.
Catherine VerfaillieDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38871840
PMCPMC11176091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.